Education
About Us
Working with TipRanks
Follow Us
Granules India Limited (IN:GRANULES)
:GRANULES
GRANULES Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹412.05 - ₹724.55
Previous CloseN/A
Volume528.44K
Average Volume (3M)29.43K
Market Cap
₹113.78B
Enterprise Value₹126.45B
Total Cash (Recent Filing)₹2.17B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)22.7
Beta1.27
Next Earnings
Aug 12, 2025EPS Estimate
5.3Next Dividend Ex-Date
Jul 31, 2025Dividend Yield0.32%
Share Statistics
EPS (TTM)5.15
Shares Outstanding242,643,720
10 Day Avg. Volume25,061
30 Day Avg. Volume29,427
Financial Highlights & Ratios
PEG Ratio5.04
Price to Book (P/B)3.17
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Granules India Limited News
PremiumCompany Announcements
Granules India Limited Announces Change in Registered Office Location
PremiumCompany Announcements
Granules India Allots 50,000 Shares Under ESOS 2009GRANULES FAQ
What was Granules India Limited’s price range in the past 12 months?
Granules India Limited lowest stock price was ₹412.05 and its highest was ₹724.55 in the past 12 months.
What is Granules India Limited’s market cap?
Granules India Limited’s market cap is ₹113.78B.
When is Granules India Limited’s upcoming earnings report date?
Granules India Limited’s upcoming earnings report date is Aug 12, 2025 which is in 27 days.
How were Granules India Limited’s earnings last quarter?
Granules India Limited released its earnings results on May 28, 2025. The company reported ₹5.15 earnings per share for the quarter, missing the consensus estimate of ₹5.25 by -₹0.1.
Is Granules India Limited overvalued?
According to Wall Street analysts Granules India Limited’s price is currently Overvalued.
Does Granules India Limited pay dividends?
Granules India Limited pays a Annually dividend of ₹1.5 which represents an annual dividend yield of 0.32%. See more information on Granules India Limited dividends here
What is Granules India Limited’s EPS estimate?
Granules India Limited’s EPS estimate is 5.3.
How many shares outstanding does Granules India Limited have?
Granules India Limited has 242,643,720 shares outstanding.
What happened to Granules India Limited’s price movement after its last earnings report?
Granules India Limited reported an EPS of ₹5.15 in its last earnings report, missing expectations of ₹5.25. Following the earnings report the stock price went down -1.286%.
Which hedge fund is a major shareholder of Granules India Limited?
Currently, no hedge funds are holding shares in IN:GRANULES
Company Description
Granules India Limited
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.
Technical Analysis
Alembic Pharmaceuticals Limited
―
Aurobindo Pharma Ltd
―
Cipla Ltd
―
Glenmark Pharmaceuticals Limited
―
Sanofi India Limited
―